EagleTribune.com, North Andover, MA

World/National News

June 1, 2014

New drugs may make a dent in some cancer

CHICAGO (AP) — New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost. For the first time in a decade, an experimental drug has extended the lives of patients with advanced lung cancer who relapsed after standard chemotherapy. But the drug used in the study gave patients just six extra weeks of life on average, and costs $6,000 per infusion as currently sold to treat a different form of cancer.

Eli Lilly and Co.’s drug, Cryamza, was discussed Saturday at a cancer conference in Chicago, where other studies showed:

n The drug Imbruvica, sold by Pharmacyclics Inc. and Janssen Biotech, substantially improved survival and could set a new standard of care for relapsed chronic lymphocytic leukemia, or CLL, the most common leukemia in adults. Doctors say the pill more precisely targets cancer and is a good option for older people who can’t tolerate standard chemotherapy infusions.

n Two experimental pills from AstraZeneca PLC worked much better than one alone against ovarian cancer that resisted or came back after standard chemo. The drugs significantly prolonged the time women lived without their disease worsening.

LUNG CANCER

Cyramza is sold now to treat stomach cancer and fights the formation of blood vessels that feed tumors. French researchers led a study with 1,253 patients who relapsed after initial treatment of advanced lung cancer, a more common disease.

All were given the chemo drug docetaxel and half also received Cyramza infusions every three weeks. Median overall survival was 10.5 months for those on the combo and 9 months for the others; there were significantly more side effects with the combo.

“I don’t think a six-week increment is that impressive” for survival, said Dr. Derek Raghavan, an independent expert and president of the Levine Cancer Institute at Carolinas HealthCare System in Charlotte, North Carolina. He also is on a task force on value in cancer care for the American Society of Clinical Oncology, the group hosting the conference.

Text Only | Photo Reprints
Latest News
World/National News

Latest U.S. News
Obama: World Is Appalled by Murder of Journalist Pres. George W. Bush Takes Ice Bucket Challenge Changes Coming to No-Fly List Police: Ferguson More Peaceful Fire Crews Tame Yosemite Fire Raw: Police Weapon Drawn Near Protesters, Media Arrests Witnessed in Ferguson Charter Schools Alter Post-Katrina Landscape Texas Gov. Perry: Indictment 'a Political Act' US Officials: Video Shows American's Beheading Heavy Rains Flood Arizona Roads Video Shows Ferguson Cop Months Before Shooting US Trying to Verify Video of American's Killing FBI Director Addresses Ferguson Shooting in Utah Raw: Police at Scene of St. Louis Shooting Police: 2 Calif. Boys Planned School Shooting NOLA Police Chief Retires Amid Violent Crimes Lunch Bus Delivers Meals to Kids Out of School Water Bottles Recalled for Safety Researcher Testing On-Field Concussion Scanners
Latest World News
Israel, Militants Trade Fire After Talks Fail Raw: IDF Footage Said to Show Airstrikes Raw: Aftermath of Airstrike in Gaza Raw: Thousands March on Pakistani Parliament Raw: World's Oldest Man Lives in Japan Raw: Deadly Landslides in Japan Raw: Explosions in Gaza As Airstrikes Resume Today in History August 20 US Officials: Video Shows American's Beheading US Trying to Verify Video of American's Killing Rockets Fired From Gaza, in Breach of Ceasefire Raw: Japanese Military Live Fire Exercise Today in History August 19 Raw: Russian Aid Convoy Crosses Into Ukraine Raw: Building Collapse in South Africa, 9 Dead Assange Gets Cryptic About Leaving Embassy in UK Raw: Pope Francis Meets 'Comfort Women' Kurdish Peshmergas Retake Mosul Dam WikiLeaks Founder Says He'll Leave Embassy Soon Raw: Israel Destroys Killing Suspects' Homes
Photos of the Week